Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Ryan Prebble

Nurse Practitioner, Acute Care Wichita, KS Nurse Practitioner

NPI 1730697012 CMS profile 10751459

3600 E Harry St, Wichita, KS 67218

Open in the dashboard

General payments

$2,703

180 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ryan Prebble of Wichita, KS is reported in the CMS Open Payments database as having received $2,703 across 180 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 88th percentile of Nurse Practitioner, Acute Care profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,120 66
2024 General $963 68
2023 General $354 25
2022 General $116 9
2021 General $149 12

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ryan Prebble
  • Nurse Practitioner, Acute Care median
  • Middle half of Nurse Practitioner, Acute Care
  • National median

In program year 2025, general payments to Ryan Prebble were reported at $1,120. Among 11,827 Nurse Practitioner, Acute Care profiles paid that year, the median was $152 and the middle half received between $48 and $458.

Show as a table
Year Ryan Prebble Nurse Practitioner, Acute Care median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $149 $123 $38–$327 $132
2022 $116 $130 $44–$369 $149
2023 $354 $144 $49–$410 $160
2024 $963 $146 $48–$433 $164
2025 $1,120 $152 $48–$458 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Globus Medical, Inc. $2,489 176 payments
  2. CTL Medical Corporation $189 3 payments
  3. Fidia Pharma USA Inc. $24 1 payment

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,703 180 payments
Products named General payments · program years 2021–2025
  1. CREO $353 19 payments
  2. EXCELSIUS GPS Spine/Spine Surgery $232 18 payments
  3. Excelsius3D Imaging System $205 14 payments
  4. ExcelsiusGPS Robotic Navigation System $202 15 payments
  5. Raphael Pedicle Screw System $189 3 payments
  6. Hedron IA $182 14 payments
  7. CREO Threaded $137 10 payments
  8. QUARTEX $116 9 payments
  9. EXCELSIUS GPS Spine/Joint $102 9 payments
  10. Hedron $92 7 payments
  11. Other $918 63 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 11 drugs

Part D claims

635

Median for Nurse Practitioner: 389

Drug cost

$5,992

Median for Nurse Practitioner: $21,885

Branded share of claims

50.4%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 176 $2,448
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 144 $1,599
Tizanidine Hcl Generic 75 $704
Methocarbamol Generic 27 $383
Oxycodone Hcl Generic 47 $270
Meloxicam Generic 64 $186
Cyclobenzaprine Hcl Generic 21 $139
Methylprednisolone Generic 23 $136
Diazepam Generic 29 $72
Tramadol Hcl Generic 13 $35

The 10 drugs with the highest cost, of 11 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 23 billing codes

Paid by Medicare

$20,298

Medicare's payments for the services billed

Medicare patients

81

Average age 72

Services billed

281

34 women, 47 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Diabetes 41%
Ischemic heart disease 38%
Depression 37%
Chronic kidney disease 22%
COPD 20%
Heart failure 16%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

180 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Acute Care in Kansas

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record